| Patents for A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids) (127,169) |
|---|
| 08/03/1999 | US5932576 3(5)-heteroaryl substituted pyrazoles as p38 kinase inhibitors |
| 08/03/1999 | US5932565 Vitamin D analogues |
| 08/03/1999 | US5932560 Treatment of conditions and disease |
| 08/03/1999 | US5932470 Ectoparasite saliva proteins and apparatus to collect such proteins |
| 08/03/1999 | US5932459 Artificial tissues, methods for the production and the use thereof |
| 08/03/1999 | US5932425 Compositions and methods for modulating cellular NF-κB activation |
| 08/03/1999 | US5932423 Cyclic nucleotide phosphodiesterases |
| 08/03/1999 | US5932217 Peptides which inhibit adhesion between leukocytes and endothelial cells |
| 08/03/1999 | US5932214 Treatment for inflammatory bowel disease with VLA-4 blockers |
| 08/03/1999 | US5932208 Compositions and methods for the use of such compositions in human therapeutics, characterized by the association of a muramyl peptide with a cytokine |
| 07/30/1999 | CA2246001A1 Novel compounds |
| 07/29/1999 | WO1999037818A1 Novel molecules of the tnf receptor superfamily and uses therefor |
| 07/29/1999 | WO1999037760A1 Inhibition of cytokine production |
| 07/29/1999 | WO1999037682A2 Antibodies against human il-12 |
| 07/29/1999 | WO1999037674A1 Secreted proteins and polynucleotides encoding them |
| 07/29/1999 | WO1999037668A1 Thrombin inhibitors |
| 07/29/1999 | WO1999037651A1 Chemokine receptor antagonists and methods of use therefor |
| 07/29/1999 | WO1999037625A1 2,3,4,5-tetrahydro-1h-[1,4]-benzodiazepine-3-hydroxamic acids as matrix metalloproteinase inhibitors |
| 07/29/1999 | WO1999037622A1 Nitrogenous heterocyclic derivatives and medicine thereof |
| 07/29/1999 | WO1999037621A1 Novel sulfonamide derivatives as inhibitors of bone resorption and as inhibitors of cell adhesion |
| 07/29/1999 | WO1999037619A1 Chemokine receptor antagonists and methods of use therefor |
| 07/29/1999 | WO1999037618A1 Phenylalanine derivatives useful as pharmaceutical agents |
| 07/29/1999 | WO1999037611A1 Heterocyclic amidines as callicrein protease inhibitors |
| 07/29/1999 | WO1999037600A1 Diterpene derivatives and anti-inflammatory analgesic agents comprising the same |
| 07/29/1999 | WO1999037318A1 Histone containing composition to treat rheumatoid arthritis |
| 07/29/1999 | WO1999037314A1 Sea cucumber carotenoid lipid fraction products and methods of use |
| 07/29/1999 | WO1999021617A3 Allosteric adenosine receptor modulators |
| 07/29/1999 | WO1998050530A3 Enzymatic nucleic acids: synthesis, selection and use |
| 07/29/1999 | CA2319077A1 Chemokine receptor antagonists and methods of use therefor |
| 07/29/1999 | CA2318935A1 Phagocytosis genes and uses thereof |
| 07/29/1999 | CA2318743A1 Novel molecules of the tnf receptor superfamily and uses therefor |
| 07/29/1999 | CA2318303A1 Secreted proteins and polynucleotides encoding them |
| 07/29/1999 | CA2318221A1 Novel sulfonamide derivatives as inhibitors of bone resorption and as inhibitors of cell adhesion |
| 07/29/1999 | CA2318088A1 Chemokine receptor antagonists and methods of use therefor |
| 07/29/1999 | CA2317839A1 Inhibition of cytokine production |
| 07/29/1999 | CA2317761A1 Thrombin inhibitors |
| 07/29/1999 | CA2317546A1 2,3,4,5-tetrahydro-1h-¬1,4|-benzodiazepine-3-hydroxamic acids as matrix metalloproteinase inhibitors |
| 07/28/1999 | EP0931788A2 Metalloprotease inhibitors |
| 07/28/1999 | EP0931096A2 HT m4?, METHODS OF TREATMENT AND ASSAYS, AGONISTS AND ANTAGONISTS |
| 07/28/1999 | EP0931092A2 Variants of vascular endothelial cell growth factor having antagonistic properties |
| 07/28/1999 | EP0931091A1 Inhibitors of pla 2 |
| 07/28/1999 | EP0931086A1 Tetrahydronaphthalene derivatives and their therapeutic use |
| 07/28/1999 | EP0931075A1 Indazole derivatives and their use as inhibitors of phosphodiesterase (pde) type iv and the production of tumor necrosis factor (tnf) |
| 07/28/1999 | EP0931065A2 Nitric ester derivatives and their use in urinary incontinence and other diseases |
| 07/28/1999 | EP0931063A1 N-substituted indol-3-glyoxylamid with antiasthmatic, antiallergic and immunosuppressive/immunomodulating effect |
| 07/28/1999 | EP0931045A1 Matrix metalloproteinase inhibitors and their therapeutic uses |
| 07/28/1999 | EP0930891A1 Oral administration of chicken yolk antibodies to treat disease |
| 07/28/1999 | EP0930886A1 Formulation for use in the prevention of pathogen induced diseases including hiv and hsv |
| 07/28/1999 | EP0874639A4 Peptide inhibitors of a phosphotyrosine-binding domain containing protein |
| 07/28/1999 | EP0766665B1 Metalloproteinase inhibitors |
| 07/28/1999 | EP0705265B1 Novel chemical compounds having pde-iv inhibition activity |
| 07/28/1999 | EP0678122B1 Recombinant anti-vla4 antibody molecules |
| 07/28/1999 | CN1224429A Androstene derivs. |
| 07/28/1999 | CN1224351A Pharmaceutical preparation contg. nimesulide for oral administration |
| 07/28/1999 | CN1223869A Multifunctional pain-relieving liquid |
| 07/27/1999 | US5929117 Immunotherapeutic agents |
| 07/27/1999 | US5929112 Use in pharmaceuticals or cosmetics as antioxidants, improved bioavailability |
| 07/27/1999 | US5929067 N-acylating amine derivative of caprolactam compound with a carboxylic acid or derivatives to form amide derivative of caprolactam compound |
| 07/27/1999 | US5929063 Mercapto and seleno derivatives as inhibitors of nitric oxide synthase |
| 07/27/1999 | US5929056 Accesible from readily available starting materials to be used for wound healing and in cosmetics |
| 07/27/1999 | US5929048 Treatment of conditions and disease |
| 07/27/1999 | US5929040 Method for the prophylaxis and/or treatment of proliferative and/or inflammatory skin disorders |
| 07/27/1999 | US5928899 Cell division regulators |
| 07/27/1999 | CA2181175C Dihydro pyrazolopyrroles |
| 07/22/1999 | WO1999036541A1 INTERLEUKIN-1 RECEPTOR ANTAGONIST BETA (IL-1RAβ) |
| 07/22/1999 | WO1999036512A1 Secreted proteins and polynucleotides encoding them |
| 07/22/1999 | WO1999036439A1 Polypeptides, dna coding therefor, formulations thereof, and their use in inhibiting factor xii activation |
| 07/22/1999 | WO1999036437A1 Antibody/receptor targeting moiety for enhanced delivery of armed ligand |
| 07/22/1999 | WO1999036426A1 N-[2-(5-BENZYLOXYCARBONYL-AMINO-6-OXO-2-(4-FLUOROPHENYL)-1,6-DIHYDRO-1-PYRIMIDINYL)ACETO- XYL]-L-ASPARTIC ACID ALDEHYDE AS AN IN VIVO INHIBITOR OF INTERLEUKIN-1β CONVERTING ENZYME (ICE) |
| 07/22/1999 | WO1999036424A1 Piperazino derivatives as neurokinin antagonists |
| 07/22/1999 | WO1999036421A1 4-(2-keto-1-benzimidazolinyl)piperidine compounds as orl1-receptor agonists |
| 07/22/1999 | WO1999036420A1 Thiophene nitrone compounds |
| 07/22/1999 | WO1999036415A1 Thioether furan nitrone compounds |
| 07/22/1999 | WO1999036409A1 Metabolically inert anti-inflammatory and anti-tumor antifolates |
| 07/22/1999 | WO1999036393A1 INHIBITORS OF α4 MEDIATED CELL ADHESION |
| 07/22/1999 | WO1999036093A1 Methods of using human receptor protein 4-1bb |
| 07/22/1999 | WO1999036077A1 Composition and method for treatment and prevention of arthritis and/or autoimmune diseases |
| 07/22/1999 | WO1999036070A1 Il-8 receptor antagonists |
| 07/22/1999 | WO1999036060A1 Oral liquid compositions |
| 07/22/1999 | WO1999030157A3 Neuropilins in methods for diagnosis and prognosis of cancer |
| 07/22/1999 | WO1999024052A3 Use of protein h as cytostatic agent |
| 07/22/1999 | WO1999023208A3 RIBOZYMES TARGETED TO IL-15 mRNA |
| 07/22/1999 | WO1999016407A3 Method and system for pain management |
| 07/22/1999 | WO1999005291A3 Aggrecan degrading metallo proteases |
| 07/22/1999 | CA2319063A1 Il-8 receptor antagonists |
| 07/22/1999 | CA2318555A1 Thiophene nitrone compounds |
| 07/22/1999 | CA2318525A1 Methods of using human receptor protein 4-1bb |
| 07/22/1999 | CA2318358A1 Polypeptides, dna coding therefor, formulations thereof, and their use in inhibiting factor xii activation |
| 07/22/1999 | CA2318357A1 Thioether furan nitrone compounds |
| 07/22/1999 | CA2318284A1 Antibody/receptor targeting moiety for enhanced delivery of armed ligand |
| 07/22/1999 | CA2317813A1 Composition and method for treatment and prevention of arthritis and/or autoimmune diseases |
| 07/22/1999 | CA2317760A1 Piperazino derivatives as neurokinin antagonists |
| 07/22/1999 | CA2317392A1 Secreted proteins and polynucleotides encoding them |
| 07/22/1999 | CA2309546A1 N-[2-(5-benzyloxycarbonyl-amino-6-oxo-2-(4-fluorophenyl)-1,6-dihydro-1-pyrimidinyl)acetoxyl]-l-aspartic acid aldehyde as an in vivo inhibitor of interleukin-1.beta. converting enzyme (ice) |
| 07/21/1999 | EP0930310A1 Isocoumarin derivatives and use thereof in drugs |
| 07/21/1999 | EP0930070A1 Stable aspirin ointment preparations |
| 07/21/1999 | EP0929670A1 P-selectin ligand proteins |
| 07/21/1999 | EP0929578A1 HUMAN ANTIBODIES THAT BIND HUMAN TNFalpha |
| 07/21/1999 | EP0929571A1 4-substituted-3-(2-amino-2-cycloalkyl methyl)-acetamido azetidin-2-one derivatives as cysteine proteinase regulators |
| 07/21/1999 | EP0929557A2 (o-ACYL-p-N-ACYLAMINO-PHENYL)-O-PHOSPHOETHANOLAMINES |